Children and young people who are Black or Hispanic are less likely to be diagnosed with migraine than those who are white ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Symbravo (meloxicam and ...

A leading cardiology doctor says this reinforces the importance of studying gender-specific health trends in research.

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

After adjusting for potential confounders (age, sex, race, use of birth control, pregnancy), findings showed propranolol use was associated with a significant reduction in the risk of stroke among ...

With historical data showing migraine to be underdiagnosed and undertreated, new guidance from the American College of ...

The American College of Physicians (ACP) has developed new recommendations to prevent episodic migraines in nonpregnant ...

A common drug used to prevent migraines might have an additional benefit -- protecting women against stroke. Women taking the ...

You can use PC HelpSoft Driver Updater to do it in 3 easy steps: If the ASUS Armoury Crate’s Aura Sync is not working, it may result from software bugs, outdated drivers, or misconfigured settings.

Propranolol is associated with a reduced risk for overall stroke among women with migraine, with a more pronounced pro ...

The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or ...

An effort two decades in the making, Vertex Pharmaceuticals Inc.’s suzetrigine gained U.S. FDA approval as the first drug targeting the NaV1.8 pain signal. Branded Journavx, the oral small molecule is ...